FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1197373002: Product containing calamine and zinc oxide in cutaneous dose form (medicinal product form)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 28-Feb 2022. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4696110010 Calamine- and zinc oxide-containing product in cutaneous dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4696111014 Product containing calamine and zinc oxide in cutaneous dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4696110010 Calamine- and zinc oxide-containing product in cutaneous dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4696111014 Product containing calamine and zinc oxide in cutaneous dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

5 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Calamine- and zinc oxide-containing product in cutaneous dose form Is a Calamine- and zinc oxide-containing product true Inferred relationship Existential restriction modifier (core metadata concept)
Calamine- and zinc oxide-containing product in cutaneous dose form Is a Product containing calamine in cutaneous dose form (medicinal product form) true Inferred relationship Existential restriction modifier (core metadata concept)
Calamine- and zinc oxide-containing product in cutaneous dose form Has manufactured dose form Cutaneous dose form true Inferred relationship Existential restriction modifier (core metadata concept)
Calamine- and zinc oxide-containing product in cutaneous dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Calamine (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Calamine- and zinc oxide-containing product in cutaneous dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Zinc oxide true Inferred relationship Existential restriction modifier (core metadata concept) 2
Calamine- and zinc oxide-containing product in cutaneous dose form Is a Zinc oxide-containing product in cutaneous dose form true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Calamine and zinc oxide only product in cutaneous dose form Is a True Calamine- and zinc oxide-containing product in cutaneous dose form Inferred relationship Existential restriction modifier (core metadata concept)
Calamine- and dimeticone- and zinc oxide-containing product in cutaneous dose form Is a True Calamine- and zinc oxide-containing product in cutaneous dose form Inferred relationship Existential restriction modifier (core metadata concept)

This concept is not in any reference sets

Back to Start